ALKT
ALKAMI TECHNOLOGY, INC.
Research: Finviz ↗·Perplexity ↗
No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.
News Summary
NeutralAlkami rejected a sale after strategic review and committed to remaining independent, triggering a sharp 20% stock selloff despite Q3 revenue beating guidance (+19% YoY to $134.9M) and raised full-year guidance. The strategic review conclusion has created near-term uncertainty around client acquisition, though the company exited the review with a $56M ARR backlog and maintains strong subscription revenue growth (20% YoY).
Red flags
- •Strategic review rejection triggered 20% stock decline; market clearly preferred sale option
- •Q3 EPS missed badly: -$0.06 actual vs. +$0.20 consensus expectation despite revenue beat
- •Strategic review cited as headwind slowing new client acquisitions in near term
- •Activist investor Jana Partners continues engagement despite failed sale push, signaling ongoing governance pressure
Fund 13D/13G Filings (5)
Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).
| Fund | Form | ∆ Shares | % of Class | Since Filing | Filed | Src |
|---|---|---|---|---|---|---|
| Jana Partners | SC 13D/A | −1.4M | 5.0% | +7.2% vs SPY +1.9% abs | 2026-10-30 | ↗ |
| Jana Partners | SC 13D/A | +0 | 6.3% | -1.7% vs SPY -7.9% abs | 2026-10-16 | ↗ |
| Jana Partners | SC 13D | +1.4M | 6.3% | -23.2% vs SPY -18.8% abs | 2026-06-29 | ↗ |
| Jana Partners | SC 13D/A | −92K | 5.0% | +11.9% vs SPY +16.9% abs | 2026-05-12 | ↗ |
| Jana Partners | SC 13D | NEW | 5.1% | — | 2026-04-01 | ↗ |